Enhanced Endothelium-Dependent Relaxations After Gene Transfer of Recombinant Endothelial Nitric Oxide Synthase to Rabbit Carotid Arteries

Hypertension

Volumn 30, Issue 3, 1997, Pages 314-320

  Kullo, Iftikhar J ^a   Mozes, Geza ^a   Schwartz, Robert S ^a   Gloviczki, Peter ^a   Tsutsui, Masato ^a   Katusic, Zvonimir S ^a   O'Brien, Timothy ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHLORIDE; RECOMBINANT ENZYME; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY WALL; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE THERAPY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM;

ANIMALS; CAROTID ARTERIES; CYCLIC GMP; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; MALE; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; POTASSIUM CHLORIDE; RABBITS; RECOMBINANT PROTEINS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0030754269     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.30.3.314     Document Type: Article

References (39)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Ignarro L. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1-21.
3. Mellion BT, Ignarro LJ, Ohlstein EGH, Pontecarvo KG, Hyman AI, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3':5'-monophosphate in ADP induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981;57:946-955.
4. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651-4655.
5. Garg UC, Hassid A. Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1776.
6. Nathan C. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78:915-918.
7. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
8. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
9. Rees DD, Palmer RMJ, Moncada S. Role of endothelial derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
10. Vallance P, Collier J, Moncada S. Effects of endothelial-derived nitric oxide on peripheral arterial tone in man. Lancet. 1989;2:997-1000.
11. Busse R, Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med. 1995;27:331-340.
12. Sessa WC, Pritchard K, Sayedi N, Wang J, Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 1994;74:349-353.
13. Weiner CP, Lizasoain I, Bayliss SA, Knowles RG, Charles IC, Moncada S. Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc Natl Acad Sci U S A. 1994;91:5212-5216.
14. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 1995;38:105-128.
15. Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-548.
16. Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.
17. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev. 1993;3:499-503.
18. Schneider MD, French BA. The advent of adenovirus: gene therapy for cardiovascular disease. Circulation. 1993;88:1937-1942.
19. von der Leyen HE, Gibbons GH, Morishita H, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
20. Jansenns SP, Bloch KD, Nong Z, Gerard RD, Zoldheyi P, Collen D. Adenoviral mediated transfer human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest. 1996;98:317-324.
21. Spector DJ, Samaniego LA. Construction and isolation of recombinant adenovirus with gene replacements. Methods Mol Genet. 1995;7:31-44.
22. Graham FL, Smiley J Russell WC, Nairn R. Characteristics of a human cell line transformed by human adenovirus type 5. J Gen Virol. 1977;36:59-74.
23. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 1979;17:683-689.
24. Volkert FC, Young CS. The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. Virology. 1983;125:175-193.
25. Hope BT, Michael GJ, Knigge KM, Vincen SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A. 1991;88:2811-2814.
26. Yang Y, Raper SE, Cohn JA, Engelhardt JF, Wilson JM. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci U S A. 1993;90:4601-4605.
27. Warren BA. A method for the production of 'en face' preparations one cell in thickness. J R Micr Soc. 1965;84:407.
28. Schwartz SM, Benditt EP. Cell replication in the aortic endothelium: a new method for the study of the problem. Lab Invest. 1973;28:699-707.
29. Riese KH, Freudenberg N, Haas W. 'En face' preparation methods for investigation of endothelia and mesothelia. Pathol Res Pract. 1978;162:327-336.
30. G) -monomethyl-L-arginine in canine basilar artery. Stroke. 1991;22:1399-1404.
31. Schulick AH, Dong G, Newman KD, Virmani R, Dichek DA. Endothelium-specific in vivo gene transfer. Circ Res. 1995;77:475-485.
32. Arnold WP, Mittal CJK, Katusiki CK, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977;74:3203-3207.
33. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 1995;96:2955-2965.
34. Busse R, Mulsch A. Induction of nitric oxide synthesis by cytokines in vascular smooth muscle cells. FEBS Lett. 1990;275:87-90.
35. Wang J, Wolin MS, Hintze TH. Chronic exercise enhances endothelium-mediated dilation of epicardial coronary artery in conscious dogs. Circ Res. 1993;73:829-838.
36. Hayashi T, Fukuto JM, Ignarro LJ. Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A. 1992;89:11259-11263.
37. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects. J Med Chem. 1991;34:3242-3247.
38. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
39. Needleman P, Johnson EM Jr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973;184:709-715.